ANI Pharmaceuticals | ANIP - DÍVIDA





DÍVIDA Alterar Data
AbbVie USD 67.5B 67.5B 2025-12
ANI Pharmaceuticals USD 617.04M 3.28M 2025-12
Aurora Cannabis CAD 23.86M 76.48M 2026-03
Canopy Growth CAD 278.71M 19.38M 2026-03
Eli Lilly USD 42.5B 3.6M 2025-12
Emergent BioSolutions USD 903.2M 495.2M 2023-06
Heron Therapeutics USD 149.65M 157K 2024-09
Hikma Pharmaceutical USD 1.56B 252M 2025-06
Knight Therapeutics CAD 77.91M 28.33M 2025-12
Nektar Therapeutics USD 0 0 2022-06
Novartis USD 47B 14.98B 2026-03
Omeros USD 442.16M 199K 2023-09
Perrigo USD 3.64B 4.5M 2025-12
Sun Pharmaceuticals INR 23.62B 2.1B 2025-03
Teva Pharmaceutical Industries USD 17.09B 21M 2025-12